Manmeet Singh Soni is COO and CFO of Summit Therapeutics Inc.. Currently has a direct ownership of 3.02 Million shares of SMMT, which is worth approximately $56.1 Million. The most recent transaction as insider was on Sep 11, 2024, when has been sold 44,052 shares (Common Stock) at a price of $22.7 per share, resulting in proceeds of $999,980. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.02M
1.48% 3M change
1.48% 12M change
Total Value Held $56.1 Million

Manmeet Singh Soni Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 11 2024
BUY
Grant, award, or other acquisition
$999,980 $22.7 p/Share
44,052 Added 1.44%
3,020,242 Common Stock
Oct 13 2023
BUY
Open market or private purchase
$4,999,999 $1.68 p/Share
2,976,190 Added 50.0%
2,976,190 Common Stock

Also insider at

RETA
REATA PHARMACEUTICALS INC Healthcare
PLSE
Pulse Biosciences, Inc. Healthcare
MSS

Manmeet Singh Soni

COO and CFO
Plano, TX

Track Institutional and Insider Activities on SMMT

Follow Summit Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SMMT shares.

Notify only if

Insider Trading

Get notified when an Summit Therapeutics Inc. insider buys or sells SMMT shares.

Notify only if

News

Receive news related to Summit Therapeutics Inc.

Track Activities on SMMT